×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: vaccine

FDA Amends J&J Vaccine Fact Sheet to Include Rare Bleeding Risk

FDA Amends J&J Vaccine Fact Sheet to Include Rare Bleeding Risk
(Dreamstime)

Tuesday, 11 January 2022 03:38 PM EST

The Food and Drug Administration on Tuesday amended the fact sheet for Johnson & Johnson's COVID-19 vaccine to include a rare risk of immune thrombocytopenia, a bleeding disorder.

"Reports of adverse events following use of the Janssen COVID-19 vaccine under emergency use authorization suggest an increased risk of immune thrombocytopenia during the 42 days following vaccination," the regulator said in a letter to J&J's arm, Janssen Biotech Inc.

The symptoms include easy bruising or tiny blood spots under the skin, or unusual or excessive bleeding, the FDA said.

The amendment fact sheet follows similar moves for the vaccine by other regulators, including that of European Medicines Agency in October https://www.reuters.com/business/healthcare-pharmaceuticals/eu-finds-jj-covid-shot-possibly-linked-another-rare-clotting-condition-2021-10-01.

Both the J&J and AstraZeneca vaccines, which are based on a similar platform, have previously been associated with another very rare combination of blood clotting and low platelet counts, known as thrombosis with thrombocytopenia syndrome.

The U.S. Centers for Disease Control and Prevention had also last month recommended Americans choose https://www.reuters.com/business/healthcare-pharmaceuticals/blood-clot-rates-after-jj-vaccine-higher-than-previous-estimates-cdc-advisers-2021-12-16 to receive one of two other authorized COVID-19 vaccines from Pfizer-BioNTech over J&J's single-dose shot, due to the rare but sometimes fatal risk. 

© 2022 Thomson/Reuters. All rights reserved.


Newsfront
The Food and Drug Administration on Tuesday amended the fact sheet for Johnson & Johnson's COVID-19 vaccine to include a rare risk of immune thrombocytopenia, a bleeding disorder."Reports of adverse events following use of the Janssen COVID-19 vaccine under emergency use...
vaccine
184
2022-38-11
Tuesday, 11 January 2022 03:38 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved